女性の性的欲求低下障害(Female Hypoactive Sexual Desire Disorder)の治療薬パイプライン動向(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Female Hypoactive Sexual Desire Disorder Overview 6
Therapeutics Development 7
Pipeline Products for Female Hypoactive Sexual Desire Disorder – Overview 7
Pipeline Products for Female Hypoactive Sexual Desire Disorder – Comparative Analysis 8
Female Hypoactive Sexual Desire Disorder – Therapeutics under Development by Companies 9
Female Hypoactive Sexual Desire Disorder – Pipeline Products Glance 10
Late Stage Products 10
Clinical Stage Products 11
Female Hypoactive Sexual Desire Disorder – Products under Development by Companies 12
Female Hypoactive Sexual Desire Disorder – Companies Involved in Therapeutics Development 13
Apricus Biosciences, Inc. 13
Palatin Technologies, Inc. 14
Female Hypoactive Sexual Desire Disorder – Therapeutics Assessment 15
Assessment by Monotherapy Products 15
Assessment by Combination Products 16
Assessment by Target 17
Assessment by Mechanism of Action 19
Assessment by Route of Administration 21
Assessment by Molecule Type 23
Drug Profiles 25
(bupropion hydrochloride + trazodone hydrochloride) – Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
(buspirone hydrochloride + testosterone) – Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
(sildenafil citrate + testosterone) – Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
alprostadil – Drug Profile 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
bremelanotide – Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
flibanserin – Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Female Hypoactive Sexual Desire Disorder – Recent Pipeline Updates 36
Female Hypoactive Sexual Desire Disorder – Dormant Projects 44
Female Hypoactive Sexual Desire Disorder – Product Development Milestones 45
Featured News & Press Releases 45
Jul 29, 2013: S1 Biopharma Doses First Patients in Phase 2a Clinical Trial of Lorexys in Premenopausal Women with HSDD 45
Feb 20, 2012: S1 Pharma Submits IND Application For SIP-104 For Treatment Of Hypoactive Sexual Desire Disorder 46
Appendix 47
Methodology 47
Coverage 47
Secondary Research 47
Primary Research 47
Expert Panel Validation 47
Contact Us 48
Disclaimer 48


【レポート販売概要】

■ タイトル:女性の性的欲求低下障害(Female Hypoactive Sexual Desire Disorder)の治療薬パイプライン動向(2015年上半期版)
■ 英文:Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2015
■ 発行日:2015年1月22日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6096IDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。